Table 1 Characteristics of responder and non-responder patients after fluid infusion and leg raising
Responders (n = 21) | Non-responders (n = 36) | P value | |
|---|---|---|---|
Age (years) | 63.2 ± 8.9 | 66.0 ± 8.7 | 0.2534 |
Sex (men/women) | 17/4 | 33/3 | 0.2345 |
Height (cm) | 169.1 ± 8.7 | 168.4 ± 7.5 | 0.7374 |
Weight (kg) | 80.9 ± 17.0 | 82.6 ± 16.2 | 0.7164 |
LVEF (%) | 54.1 ± 10.4 | 53.3 ± 11.4 | 0.7954 |
LVH (n) | 1 (4.8%) | 2 (5.6%) | 0.8913 |
Euroscore | 1.6 (0.7, 3.0) | 2.6 (1.1, 4.0) | 0.1397 |
Renal insufficiency (n) | 5 (23.8%) | 10 (27.8%) | 0.7428 |
HTA (n) | 17 (81.0%) | 32 (88.9%) | 0.4053 |
Diabetes (n) | 5 (23.8%) | 13 (19.7%) | 0.3351 |
Peripheral vascular disease (n) | 1 (4.8%) | 7 (19.4%) | 0.1237 |
Previous stroke (n) | 2 (9.5%) | 5 (13.9%) | 0.6281 |
COPD (n) | 1 (4.8%) | 8 (22.2%) | 0.0812 |
Beta-blockers (n) | 15 (71.4%) | 28 (77.8%) | 0.5911 |
Calcium channel blockers (n) | 7 (33.3%) | 16 (44.4%) | 0.4095 |
ACE inhibitors (n) | 10 (47.6%) | 22 (61.1%) | 0.3221 |
Diuretics (n) | 5 (23.8%) | 8 (22.2%) | 0.8904 |
Statins (n) | 18 (85.7%) | 35 (97.2%) | 0.1009 |